J&J To Get EU Fast-Track Decision On Apalutamide

 
• By Maureen Kenny

J&J is hoping EU regulators will follow the US in fast-tracking the company’s prostate cancer franchise-extending drug apalutamide.

Fast Track
Will apalutamide get a speedy review in EU? • Source: Shutterstock

More from Europe

More from Geography